BRPI0508080A - emprego de derivados de amida de metileno em distúrbios cardiovasculares - Google Patents

emprego de derivados de amida de metileno em distúrbios cardiovasculares

Info

Publication number
BRPI0508080A
BRPI0508080A BRPI0508080-0A BRPI0508080A BRPI0508080A BR PI0508080 A BRPI0508080 A BR PI0508080A BR PI0508080 A BRPI0508080 A BR PI0508080A BR PI0508080 A BRPI0508080 A BR PI0508080A
Authority
BR
Brazil
Prior art keywords
amide derivatives
cardiovascular disorders
methylene amide
prevention
formula
Prior art date
Application number
BRPI0508080-0A
Other languages
English (en)
Inventor
Rob Hooft Van Huijsduijnen
Vincent Richard
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BRPI0508080A publication Critical patent/BRPI0508080A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"EMPREGO DE DERIVADOS DE AMIDA DE METILENO EM DISTúRBIOS CARDIOVASCULARES". A presente invenção refere-se ao uso de derivados de amida de metileno substituído de Fórmula (I) para o tratamento e/ou prevenção de distúrbios cardiovasculares tais como obstrução de coronária e insuficiência cardíaca. Em particular, a presente invenção refere-se ao uso de derivados de amida de metileno substituído de Fórmula (I) em particular para o tratamento e/ou prevenção de disfunção endotelial em insuficiência cardíaca.
BRPI0508080-0A 2004-02-27 2005-02-25 emprego de derivados de amida de metileno em distúrbios cardiovasculares BRPI0508080A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100778 2004-02-27
PCT/EP2005/050823 WO2005082347A1 (en) 2004-02-27 2005-02-25 Use of methylene amide derivatives in cardiovascular disorders

Publications (1)

Publication Number Publication Date
BRPI0508080A true BRPI0508080A (pt) 2007-07-17

Family

ID=34896106

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508080-0A BRPI0508080A (pt) 2004-02-27 2005-02-25 emprego de derivados de amida de metileno em distúrbios cardiovasculares

Country Status (24)

Country Link
US (1) US20070185118A1 (pt)
EP (1) EP1732534B1 (pt)
JP (1) JP5001138B2 (pt)
KR (1) KR101188940B1 (pt)
CN (1) CN1933827B (pt)
AT (1) ATE401877T1 (pt)
AU (1) AU2005216649B2 (pt)
BR (1) BRPI0508080A (pt)
CA (1) CA2554919C (pt)
CY (1) CY1108252T1 (pt)
DE (1) DE602005008412D1 (pt)
DK (1) DK1732534T3 (pt)
EA (1) EA011811B1 (pt)
ES (1) ES2308458T3 (pt)
HK (1) HK1098073A1 (pt)
HR (1) HRP20080367T3 (pt)
IL (1) IL177494A (pt)
NO (1) NO20064295L (pt)
PL (1) PL1732534T3 (pt)
PT (1) PT1732534E (pt)
RS (1) RS50596B (pt)
SI (1) SI1732534T1 (pt)
UA (1) UA84453C2 (pt)
WO (1) WO2005082347A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100410236C (zh) * 2002-01-29 2008-08-13 雪兰诺实验室有限公司 作为蛋白酪氨酸磷酸酶调节剂的取代亚甲基酰胺衍生物
ATE455772T1 (de) 2003-07-21 2010-02-15 Merck Serono Sa Alkinylarylcarbonsäureamide
EP2072498A4 (en) * 2006-10-12 2012-07-18 Inst Med Molecular Design Inc N-PHENYLOXAMIDE ACID DERIVATIVE
US8633245B2 (en) * 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
JP2014529627A (ja) 2011-08-29 2014-11-13 ティコナ・エルエルシー 芳香族アミド化合物
WO2013032975A1 (en) 2011-08-29 2013-03-07 Ticona Llc Thermotropic liquid crystalline polymer with improved low shear viscosity
CN103764793B (zh) 2011-08-29 2016-09-14 提克纳有限责任公司 高流动液晶聚合物组合物
WO2013032967A1 (en) 2011-08-29 2013-03-07 Ticona Llc Cast molded parts formed form a liquid crystalline polymer
CN103764794B (zh) 2011-08-29 2016-05-18 提克纳有限责任公司 高流动液晶聚合物组合物
US8669341B2 (en) 2011-08-29 2014-03-11 Ticona Llc Solid-state polymerization of a liquid crystalline polymer
JP2014525499A (ja) 2011-08-29 2014-09-29 ティコナ・エルエルシー 低い融解温度をもつ耐熱性液晶ポリマー組成物
US8852730B2 (en) 2011-08-29 2014-10-07 Ticona Llc Melt-extruded substrate for use in thermoformed articles
JP2014525500A (ja) 2011-08-29 2014-09-29 ティコナ・エルエルシー 低溶融粘度液晶ポリマーの溶融重合
US20150337212A1 (en) 2012-12-17 2015-11-26 Shell Oil Company Integrated gas-to-liquids condensate process
WO2014130275A2 (en) 2013-02-22 2014-08-28 Ticona Llc High performance polymer composition with improved flow properties
JP6625050B2 (ja) 2013-06-07 2019-12-25 ティコナ・エルエルシー 高強度サーモトロピック液晶ポリマー

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019830A1 (en) * 1999-09-10 2001-03-22 Novo Nordisk A/S MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
US6627767B2 (en) * 2000-08-29 2003-09-30 Abbott Laboratories Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
DE10117823A1 (de) * 2001-04-10 2002-10-17 Merck Patent Gmbh Oxalsäurederivate
AR034374A1 (es) * 2001-06-07 2004-02-18 Wyeth Corp Combinacion de un inhibidor de ptpasa y un inhibidor de ace
US20030022896A1 (en) * 2001-06-07 2003-01-30 Wyeth PTPase inhibitors for improving cardiovascular risk profile
CN100410236C (zh) * 2002-01-29 2008-08-13 雪兰诺实验室有限公司 作为蛋白酪氨酸磷酸酶调节剂的取代亚甲基酰胺衍生物

Also Published As

Publication number Publication date
KR101188940B1 (ko) 2012-10-08
AU2005216649A1 (en) 2005-09-09
PL1732534T3 (pl) 2008-12-31
IL177494A (en) 2011-06-30
JP5001138B2 (ja) 2012-08-15
CN1933827A (zh) 2007-03-21
CY1108252T1 (el) 2014-02-12
NO20064295L (no) 2006-09-22
KR20060129066A (ko) 2006-12-14
SI1732534T1 (sl) 2008-10-31
CA2554919C (en) 2013-04-16
WO2005082347A1 (en) 2005-09-09
IL177494A0 (en) 2006-12-31
DE602005008412D1 (de) 2008-09-04
EA200601511A1 (ru) 2007-02-27
CN1933827B (zh) 2011-07-27
EA011811B1 (ru) 2009-06-30
HK1098073A1 (en) 2007-07-13
US20070185118A1 (en) 2007-08-09
RS50596B (sr) 2010-05-07
DK1732534T3 (da) 2008-11-17
EP1732534A1 (en) 2006-12-20
PT1732534E (pt) 2008-08-08
ATE401877T1 (de) 2008-08-15
EP1732534B1 (en) 2008-07-23
JP2007524701A (ja) 2007-08-30
ES2308458T3 (es) 2008-12-01
HRP20080367T3 (en) 2008-09-30
UA84453C2 (ru) 2008-10-27
AU2005216649B2 (en) 2010-09-09
CA2554919A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
BRPI0508080A (pt) emprego de derivados de amida de metileno em distúrbios cardiovasculares
NO20065320L (no) Imidazolderivater anvendt som tafiainhibitorer
NO20076094L (no) Pyrimidine derivatives and their use as p2y12 receptor antagonists
ME01285A (me) Derivati dioksa-bicikl0[3.2.1]oktan-2,3,4-triola
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
NO20071343L (no) Substituerte fenylaminotiazoler og anvendelse derav
ATE505191T1 (de) Ectoin zur behandlung von vascular leaks
ATE433966T1 (de) Methylendipiperidinderivate
ATE553093T1 (de) Indazolderivate zur hemmung von trpv1 und verwendungen davon
NO20091489L (no) Tiazolpyrazolopyridiner som CRF1 reseptorantagonister
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
MY153719A (en) Prokineticin 1 receptor antagonists
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
ATE467636T1 (de) Pyrazoloä3 , 4-düazepinderivate als histamin-h3- antagonisten
DE60221425D1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren
TW200716616A (en) Modulators of CCR-5 activity
ATE407119T1 (de) Pyridinderivate und deren verwendung als modulatoren des cb2-rezeptors
MA33915B1 (fr) Nouveaux derives d' (heterocycle-piperidine condensee)-(piperazinyl)-1-alcanone ou d' (heterocycle-pyrrolidine condensee)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
ATE547105T1 (de) Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems
EA200602084A1 (ru) Пиперазиновые производные алкилоксиндолов
NO20073610L (no) Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
EA200602080A1 (ru) Пиперазиновые производные алкилоксиндолов
EA200602082A1 (ru) Производные индол-2-она для лечения расстройств центральной нервной системы, желудочно-кишечных расстройств и сердечно-сосудистых расстройств
MX2007004535A (es) Antagonistas de integrinas bifenilicos.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B25D Requested change of name of applicant approved

Owner name: MERCK SERONO S.A. (CH)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.